1. Home
  2. BLTE vs NEU Comparison

BLTE vs NEU Comparison

Compare BLTE & NEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$162.37

Market Cap

6.5B

Sector

Health Care

ML Signal

N/A

Logo NewMarket Corp

NEU

NewMarket Corp

N/A

Current Price

$613.48

Market Cap

5.6B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BLTE
NEU
Founded
2018
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.6B
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
BLTE
NEU
Price
$162.37
$613.48
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$181.14
N/A
AVG Volume (30 Days)
164.5K
132.2K
Earning Date
03-02-2026
04-22-2026
Dividend Yield
N/A
1.96%
EPS Growth
N/A
N/A
EPS
N/A
44.44
Revenue
N/A
$2,725,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$218.41
N/A
P/E Ratio
N/A
$13.83
Revenue Growth
N/A
N/A
52 Week Low
$49.00
$510.07
52 Week High
$200.00
$875.97

Technical Indicators

Market Signals
Indicator
BLTE
NEU
Relative Strength Index (RSI) 38.16 44.95
Support Level $148.78 $582.93
Resistance Level $165.64 $646.28
Average True Range (ATR) 8.78 19.42
MACD -2.47 1.61
Stochastic Oscillator 13.14 49.96

Price Performance

Historical Comparison
BLTE
NEU

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About NEU NewMarket Corp

NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives used in lubricating oils and fuels to enhance performance. The company operates through two segments: petroleum additives, mainly represented by Afton, where lubricant additives improve the efficiency and durability of base fluids and fuel additives help meet fuel specifications and improve fuel performance, and specialty materials, represented by AMPAC and Calca, including the antiknock compounds business of Ethyl, where primary raw materials include electricity, sodium chlorate, ammonia, chlorine, caustic, and hydrochloric acid, with graphite used in electrolytic cells. The company has operations in North America, Latin America, Asia Pacific, and EMEAI regions.

Share on Social Networks: